musculoskeletal disorders, rheumatism and connective tissue diseases, rheumatism, connective tissue diseases
RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.
RSC Medicinal Chemistry publishes significant research in medicinal chemistry and related drug discovery science. Research articles published in RSC Medicinal Chemistry must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Topics within the journal's scope include, but are not limited to: design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities; modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value; novel methodologies and technologies in the broader chemical and biological sciences; computational, machine learning and artificial intelligence (AI) studies are welcome where they significantly advance medicinal chemistry knowledge; studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics; studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence; studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors.
RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Research published in RSC Pharmaceutics promotes step-change science in the field of Pharmaceutics, and, as such, all submissions must show clear innovation, be scientifically sound, and have a significant impact on the field. Research sharing new scientific findings from across the areas of chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery are all welcomed. Topics include but are not limited to: • Formulation and design of medicines • Design and characterization of correct dosage forms • Physicochemical and biological properties of drugs and their carriers • Drug delivery devices and their mechanisms of release
Recent Patents on Biotechnology publishes review and research articles, and guest edited thematic issues on recent patents in the field of biotechnology. A selection of important and recent patents on biotechnology is also included in the journal. The journal is essential reading for all researchers involved in all fields of biotechnology.
Recent Patents on Inflammation & Allergy Drug Discovery publishes full-length/mini reviews and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of inflammation and allergy drug discovery e.g. on novel bioactive compounds, analogs and targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in inflammation and allergy drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to inflammation and allergy drug discovery.
1887-The beginnings of the journalResearch in Microbiology is the direct descendant of the original Pasteur periodical entitled Annales de l'Institut Pasteur, created in 1887 by Emile Duclaux under the patronage of Louis Pasteur. The Editorial Committee included Chamberland, Grancher, Nocard, Roux and Straus, and the first issue began with Louis Pasteur's "Lettre sur la Rage" which clearly defines the spirit of the journal:"You have informed me, my dear Duclaux, that you intend to start a monthly collection of articles entitled "Annales de l'Institut Pasteur". You will be rendering a service that will be appreciated by the ever increasing number of young scientists who are attracted to microbiological studies. In your Annales, our laboratory research will of course occupy a central position, but the work from outside groups that you intend to publish will be a source of competitive stimulation for all of us."That first volume included 53 articles as well as critical reviews and book reviews. From that time on, the Annales appeared regularly every month, without interruption, even during the two world wars. Although the journal has undergone many changes over the past 100 years (in the title, the format, the language) reflecting the evolution in scientific publishing, it has consistently maintained the Pasteur tradition by publishing original reports on all aspects of microbiology.Originally founded as the " Annales de l'Institut Pasteur ", Research in Microbiology has been a leading source of up-to-date information in the field of microbiology for more than a century. It publishes papers based on original research in fundamental and applied biology of bacteria, archaea and lower eukaryotes. It covers all aspects of the microbial taxonomy, phylogeny, ecology, physiology and metabolism, molecular genetics and genomics, as well as the interactions between microbes and interactions of microbes with their environment. Research in Microbiology currently publishes 10 issues a year, including an annual Forum issue, original articles, reviews, and letters to the Editor.Indexed in Medline, Excerpta Medica / EMbase, Science Citation Index, Current Contents (Life Sciences)On-line services:For on-line submission:http://pasteur.fontismedia.com/res/ For full-text articles, abstracts, contents, references: http://www.sciencedirect.com For the journal homepage at Elsevier:http://www.elsevier.com/locate/resmic
Results in Immunology is the new online only, open access journal covering all aspects of immunology. All papers published within the journal have been peer reviewed and evaluated on the basis of scientific soundness.The acceptance criteria - All papers published in Results in Immunology have undergone full peer review and must be:• Scientifically sound.• In compliance with international research and publishing ethics.• Written in clear, concise and correct English.• A valid contribution to the existing literature, and of educational value to the specific community and readers.• Not previously published material.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Retrovirology is a stringently peer-reviewed journal edited by Kuan-Teh Jeang (USA), Monsef Benkirane (France), Ben Berkhout (the Netherlands), Masahiro Fujii (Japan), Ariberto Fassati (UK), Michael Lairmore (USA), Andrew Lever (UK), and Mark Wainberg (Canada) with the assistance of an internationally renowned Editorial Board.
The areas of environmental science and environmental (bio)technology are broad, multidisciplinary, fast growing and extremely active. The last twenty years have seen an overwhelming accumulation of data, and a panoply of important discoveries. It is almost impossible to keep up to date on current developments in these areas, let alone judge their long-term significance. The purpose of Reviews in Environmental Science and Bio/Technology is twofold: to keep the reader up-to-date on achieved advances in the multidisciplinary and rapidly expanding fields of environmental science and biotechnology, and to offer perspectives on where these developments will lead. The journal comprises of two distinct peer-reviewed sections: one offering Mini-Reviews expressing scientific opinions on topics and trends, and another presenting comprehensive critical evaluations (Reviews) of research efforts and technical realizations in particular areas. In addition to these two sections, the journal will publish research and policy-o
This quarterly review journal provides balanced coverage of the field of medical microbiology. State-of-the-art reviews present the latest developments and techniques in medical microbiology, virology, mycology, parasitology, clinical microbiology, and hospital infection. Every review provides a concise, authoritative, and readable synthesis of the latest information. References are restricted to the fifty key sources in each case. 160;.
Virologists are acquisitive investigators who wish to apply the latest scientific developments to their own work. The aim of Reviews in Medical Virology is therefore to provide them with articles reviewing conceptual or technological advances in diverse areas of virology. Topics covered will include the molecular biology, cell biology, replication, pathogenesis, immunology, immunization, epidemiology, diagnosis or treatment of viruses of medical importance.
La
The journal is an organ for the dissemination of the Brazilian College of Veterinary Parasitology, with specificity only within that area, disseminating the results of Brazilian research in the areas of Helminthology, Protozoology, Entomology and agents transmitted by arthropods, related to animal health.
REVISTA IBEROAMERICANA DE MICOLOGÍA (IberoAmerican Journal of Mycology), the official journal of the Spanish, Venezuelan and Argentinean Mycology Associations (Asociación Española de Micología, Asociación Venezolana de Micología and Asociación Argentina de Micología), considers for publication, original articles, reviews, Mycology Forum, editorials, special articles, notes, and letters to the editor. All scientific contributions will be subject to an external anonymous peer review process. Articles published in REVISTA IBEROAMERICANA DE MICOLOGÍA are abstracted and indexed in Biological Abstracts, Chemical Abstracts, Current Contents/ISI Web of Science, Excerpta Medica, Índice Médico Español (Spanish Medical Index), Index Medicus/Medline/Pub-Med, Scirus and SCOPUS.
To publish scientific papers related to infectious and parasitic diseases, preventive medicine, public health and related subjects.